Invention Grant
- Patent Title: Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
- Patent Title (中): 使用V型磷酸二酯酶抑制剂治疗运动引起的马出血性肺出血
-
Application No.: US11799248Application Date: 2007-05-01
-
Publication No.: US08217049B2Publication Date: 2012-07-10
- Inventor: Bryan J. Perry
- Applicant: Bryan J. Perry
- Applicant Address: US NY West Seneca
- Assignee: ANOxA Corp.
- Current Assignee: ANOxA Corp.
- Current Assignee Address: US NY West Seneca
- Agent Michael F. Scalise
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/22 ; C07D487/04
Abstract:
The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.
Public/Granted literature
Information query
